FDA authorizes sale of Zyn nicotine pouches, saying public health benefits outweigh risk
Zyn and the retailers who sell the product have run afoul of regulators in recent years. The FDA in April of last year warned 119 retailers to stop selling Zyn to underage people, and the company was ordered to pay $1.2 million last year for violating Washington, D.C.’s smokeless tobacco ban.
Altria Group stock outperformed the S&P 500 over the past year (total return), something you don't hear about so often. See ...
Shares of Altria Group, Inc. (NYSE:MO – Get Free Report) have received an average recommendation of “Hold” from the eight ...
U.S. regulators are proposing to cap the amount of nicotine in cigarettes at non-addictive levels, in a potential world-first ...
Officials proposed limiting the amount of nicotine to make cigarettes less addictive, but it's unclear if the incoming ...
Despite the seemingly restrictive nature of the FDA's proposed ruling, I remain highly optimistic about the resilience and ...
The Biden White House is expected to formally propose a plan ordering cigarette nicotine levels to be reduced dramatically.
24/7 Wall St. on MSN10d
Altria Just Paid Investors: Here's How Much They ReceivedAltria just rewarded its shareholders again with a dividend. This high-yield stock has boosted its payout annually for more ...
Philip Morris Intl. expands into cannabis via Avicanna partnership, focusing on medical research and innovation: How this ...
Morgan Stanley began coverage on shares of Altria Group (NYSE:MO – Free Report) in a research note issued to investors on Thursday morning, Marketbeat Ratings reports. The brokerage issued an equal ...
Here are four Dividend Kings stocks that Baby Boomers can count on to deliver big and dependable payouts every quarter.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback